Gjc2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gap Junction Protein Gamma 2 is encoded by the GJC2 gene located on chromosome 6q22.31. This gene encodes connexin 46.2 (Cx46.2), a gap junction protein belonging to the connexin family. Gap junctions allow direct cell-to-cell communication by forming channels that permit passage of ions, small metabolites, and signaling molecules. GJC2 is expressed predominantly in the central nervous system and peripheral glia, where it plays critical roles in oligodendrocyte function, myelination, and astrocyte coupling. Mutations in GJC2 cause Pelizaeus-Merzbacher-like disease (PMLD), a hypomyelinating leukodystrophy.
| Gene Symbol | GJC2 |
|---|
| Full Name | Gap Junction Protein Gamma 2 (Connexin 46.2) |
|---|
| Chromosome | 6q22.31 |
|---|
| NCBI Gene ID | 57112 |
|---|
| OMIM | 608803 |
|---|
| Ensembl ID | ENSG00000146070 |
|---|
| UniProt ID | Q9NZA1 |
|---|
| Protein Length | 440 amino acids |
|---|
| Molecular Weight | 42.8 kDa |
|---|
¶ Protein Structure and Function
Connexin 46.2 has the characteristic connexin structure:
- Four transmembrane domains (TM1-TM4): Form the channel pore
- Two extracellular loops (EL1, EL2): Mediate docking with neighboring gap junction channels
- One cytoplasmic loop (CL): Intracellular loop connecting TM2 and TM3
- N-terminal domain (NT): Part of the channel pore
- C-terminal domain (CT): Cytoplasmic tail regulating channel activity
Six connexin proteins oligomerize to form a hemichannel (connexon), and two hemichannels dock to form a gap junction channel.
GJC2/Cx46.2 performs essential gap junction functions:
- Intercellular communication: Forms gap junction channels between glial cells
- K+ buffering: Facilitates spatial potassium buffering in white matter
- Metabolite transfer: Allows sharing of metabolites between astrocytes
- Calcium signaling: Participates in propagation of calcium waves
- Myelin homeostasis: Essential for oligodendrocyte function and myelination
GJC2 shows glial-specific expression:
- Oligodendrocytes: High expression in myelinating oligodendrocytes
- Astrocytes: Moderate expression, especially in white matter astrocytes
- Schwann cells: Expressed in peripheral myelinating glia
- CNS white matter: Highest expression in corpus callosum, internal capsule
- Timing: Expression increases during active myelination periods
| Disease |
Mechanism |
Evidence |
| Pelizaeus-Merzbacher-like disease (PMLD) |
Hypomorphic mutations cause severe hypomyelinization |
OMIM 608803 |
| Primary Lymphedema |
Lymphatic vessel dysfunction |
Mutations in GJC2 |
| Refsum Disease |
Possible modifier |
Genetic studies |
| Multiple Sclerosis |
Potential role in demyelination |
Expression studies |
| ALS |
Astrocyte gap junction dysfunction |
Animal models |
GJC2 is essential for proper myelination:
- Oligodendrocyte coupling: Allows metabolic support between oligodendrocytes
- Potassium clearance: Facilitates K+ homeostasis during action potential firing
- Myelin maintenance: Required for long-term myelin integrity
- Axon-oligodendrocyte signaling: Bidirectional communication
- White matter vulnerability: Explains susceptibility of white matter to demyelination
GJC2 as a therapeutic target:
- Gene therapy: AAV-mediated GJC2 delivery to CNS
- Gene replacement: Functional complementation of loss-of-function mutations
- Small molecule modulators: Gap junction openers/closers
- Combination approaches: With other myelination enhancers
Gjc2 knockout mice exhibit:
- Severe hypomyelinization
- Tremor and ataxia
- Early death
- Oligodendrocyte death
- Axonal degeneration
- Gap junction coupling in white matter physiology
- Structure-function studies of Cx46.2 channels
- Gene therapy development for PMLD
- Role in other demyelinating diseases
The study of Gjc2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- NCBI Gene: GJC2 (57112). https://www.ncbi.nlm.nih.gov/gene/57112
- UniProt Q9NZA1: Connexin 46.2. https://www.uniprot.org/uniprot/Q9NZA1
- OMIM 608803: GJC2-Related Disorder. https://www.omim.org/entry/608803
- Sutor B, et al. (2000). "Gap junctions and the development." Brain Res Rev. PMID:10784079